FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

1964711000001101: Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
266381000001116 Panadol Ultra 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare UK Ltd) 20 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
266391000001119 Panadol Ultra 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare UK Ltd) 20 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2894371000001115 Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2894381000001118 Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
24887901000001112 Panadol Ultra 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare) 20 tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
24888001000001114 Panadol Ultra 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare) 20 tablet en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Is a Co-codamol 12.8mg/500mg tablets 20 tablet true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Is pack of Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) false Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Has active ingredient Codeine phosphate false Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Has AMP Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Has specific active ingredient Codeine phosphate true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Panadol Ultra 12.8mg/500mg tablets (Haleon UK Ltd) 20 tablet Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start